Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Gastrointestinal Cancer Channel is supported with funding from Revolution Medicines (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

ESSO 45 | Comparing endoscopic versus surgical resection for early gastric cancer

Domenico D’Ugo, MD, Fondazione Policlinico Gemelli, Rome, Italy, highlights the debate surrounding the extent of resection in gastric cancer treatment. Clinicians must consider biological characteristics, such as lymphatic spread, in determining the appropriate treatment for heterogeneous tumors like esophageal and gastric cancer. This interview took place at the 2026 European Society of Surgical Oncology (ESSO) Annual Meeting in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

Yes, it’s a huge debate because we are in an era of de-escalation and organ conservation. So what we should do for the sake of having a curative resection? Could we afford a limited resection or should we ever perform something huge in order to be safe? We have already observed this phenomenon 35 years ago, when the Halstedian concept for breast cancer said, for every patient, do the maximum that you can in order to save somebody...

Yes, it’s a huge debate because we are in an era of de-escalation and organ conservation. So what we should do for the sake of having a curative resection? Could we afford a limited resection or should we ever perform something huge in order to be safe? We have already observed this phenomenon 35 years ago, when the Halstedian concept for breast cancer said, for every patient, do the maximum that you can in order to save somebody. Now it’s totally different. You should do the least that is necessary in terms of trauma and organ resection because quality of life in patients that are living a lot now is so important. The same could be applied to esophageal cancer, gastric cancer, but the differences in these cases are a little bit more complicated because these are tumors that are very heterogeneous. So it is not just the medieval concept if you should remove endoscopically something that is little and surgically something that is bigger. You should consider the biological characteristics and especially the propensity of those kind of tumors to develop lymphatic spread. Because at present, still today, lymph node involvement is the number one prognostic factor for these patients so if you totally rely based upon dimensions on endoscopic dissection you will never know anything about the lymph node spread that sometimes is small, five to ten percent, but small is not zero.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.